3Dバイオプリンティングの世界市場レポート 2025年

3Dバイオプリンティング市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR23.3％で51億1,000万米ドルに成長します。予測期間の成長は、医療の進歩、バイオプリント皮膚の開発台頭、患者の意識の高まり、高齢化などに起因します。予測期間の主要動向には、マルチマテリアル・プリンティング、脈管形成技術、臓器オンチップ、カスタムインプラント、宇宙でのバイオファブリケーションなどがあります。

3Dバイオプリンティング研究活動を支援する政府と民間資金の増加は、予測期間における3Dバイオプリンティング市場の成長を促進すると予想されます。3Dバイオプリンティングは医療への応用が増加しており、政府や民間団体からの資金援助を集めています。この資金援助は、3Dバイオプリンティング技術のさまざまな開発段階にわたって財政的技術的支援を記載しています。例えば、2022年5月、スイスを拠点とするバイオプリンティング企業Readily3d SAは、同社のTomolite 3Dバイオプリンティング技術を用いた膵臓の生体ミニチュアモデルの開発のため、欧州連合から60万米ドルの資金提供を受けた。オーストラリア保健大臣は、カーティン大学に対し、人間の皮膚修復の前段階として、皮膚組織をモデル傷口に直接バイオプリントする3D技術の開発と最適化を行うため、73万7,690米ドルの資金を提供しました。

予想される慢性疾患の増加は、3Dバイオプリンティング市場の今後の成長を牽引する要因となります。慢性疾患は、通常3ヶ月以上、多くの場合一生続くものであるため、組織モデルの作成に3Dバイオプリンティングを利用するケースが増えており、慢性疾患研究や臓器置換療法の可能性に役立っています。例えば、世界保健機関（WHO）が2022年9月に発表した報告書によると、世界全体で年間約4,100万人が死亡しており、これは死亡者数の74％に相当します。この驚くべき数字には、心血管疾患による死亡1,790万人、がんによる死亡930万人、慢性呼吸器疾患による死亡410万人、糖尿病による死亡200万人が含まれます。その結果、慢性疾患の急増が3Dバイオプリンティング市場成長の重要な促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界成長分析と戦略分析フレームワーク

• 世界の3Dバイオプリンティング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の3Dバイオプリンティング市場成長率分析
• 世界の3Dバイオプリンティング市場の実績：規模と成長、2019～2024年
• 世界の3Dバイオプリンティング市場の予測：規模と成長、2024～2029年、2034年
• 世界の3Dバイオプリンティング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の3Dバイオプリンティング市場：コンポーネント別、実績と予測、2019～2024年、2024～2029年、2034年
• 3Dバイオプリンター
• バイオインク
• 世界の3Dバイオプリンティング市場：材料別、実績と予測、2019～2024年、2024～2029年、2034年
• 生細胞
• ハイドロゲル
• 細胞外マトリックス
• その他
• 世界の3Dバイオプリンティング市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 研究用途
• 臨床用途
• その他
• 世界の3Dバイオプリンティング市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 研究機関と学術機関
• バイオ医薬品企業
• 病院
• その他
• 世界の3Dバイオプリンティング市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• インクジェット3Dバイオプリンター
• マイクロ押出3Dバイオプリンター
• レーザー支援型3Dバイオプリンター
• ステレオリソグラフィー（SLA）バイオプリンター
• 世界の3Dバイオプリンティング市場、バイオインク別、実績と予測、2019～2024年、2024～2029年、2034年
• 天然バイオインク
• 合成バイオインク
• ハイブリッドバイオインク
• ハイドロゲル

第7章 地域別・国別分析

• 世界の3Dバイオプリンティング市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の3Dバイオプリンティング市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 3Dバイオプリンティング市場：競合情勢
• 3Dバイオプリンティング市場：企業プロファイル
  • Organovo Holdings Inc.
  • Allevi Inc.
  • Cellink AB
  • Aspect Biosystems Ltd.
  • 3D Systems Corporation

第31章 その他の大手企業と革新的企業

• Cyfuse Biomedical KK
• EnvisionTEC GmbH
• Poietis SA
• TeVido BioDevices
• Nano3D Biosciences Inc.
• Digilab Inc.
• RegenHU Ltd.
• GeSiM mbH
• Advanced Solutions Life Sciences LLC
• Regenovo BIoTechnology Co. Ltd.
• Regemat 3D S.L.
• Bio3D Technologies
• Stratasys Ltd.
• ROKIT Healthcare Co. Ltd.
• Inventia Life Science Pvt. Ltd.

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、戦略

• 3Dバイオプリンティング市場2029年-最も新しい機会を提供する国
• 3Dバイオプリンティング市場2029年-最も新しい機会を提供するセグメント
• 3Dバイオプリンティング市場2029年-成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

3D Bioprinting, a form of additive manufacturing, involves the layer-by-layer printing of live structures that emulate the behavior of living systems. This process utilizes cells and biocompatible materials, commonly referred to as bio-inks. The primary application of 3D bioprinting materials is in drug research, and more recently, in the creation of cell scaffolds for repairing damaged ligaments and joints.

The key components in 3D bioprinting include 3D bioprinters and bio-inks. 3D bioprinters employ three-dimensional technology along with biocompatible materials to replicate various body parts, facilitating the bioprinting of tissues, bones, organs, blood vessels, and biomedical components. The materials involved in the process encompass living cells, hydrogels, extracellular matrices, and others. The application of 3D bioprinting extends to research and clinical settings, among others, and finds implementation in diverse sectors such as research organizations, academic institutes, biopharmaceutical companies, hospitals, and more.

The 3D bioprinting market research report is one of a series of new reports from The Business Research Company that provides 3D bioprinting market statistics, including 3D bioprinting industry global market size, regional shares, competitors with a 3D bioprinting market share, detailed 3D bioprinting market segments, market trends and opportunities, and any further data you may need to thrive in the 3D bioprinting industry. This 3D bioprinting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D bioprinting market size has grown rapidly in recent years. It will grow from $1.86 billion in 2024 to $2.21 billion in 2025 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to research and development funding, growth in chronic diseases, organ shortage, rise in pharmaceutical testing, growth in tissue engineering.

The 3D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $5.11 billion in 2029 at a compound annual growth rate (CAGR) of 23.3%. The growth in the forecast period can be attributed to healthcare advancements, rising development of bioprinted skin, growing awareness among patients, aging population. Major trends in the forecast period include multi-material printing, vascularization techniques, organ-on-a-chip, custom implants, biofabrication in space.

Rising governments and private funding to support 3D bioprinting research activities are expected to drive the growth of the 3D bioprinting market in the forecast period. 3D bioprinting is increasing applications in healthcare attracted funding from government and private organizations. This funding provides financial and technical assistance across different development phases of 3D bioprinting techniques. For instance, in May 2022, Readily3d SA, a Switzerland-based bioprinting company, received funding of $600,000 from the European Union to develop a living miniature model of the pancreas using its Tomolite 3D bioprinting technique. The Australian Minister for Health funded Curtin University with $737,690 to develop and optimize 3D technology for bioprinting skin tissue directly onto model wounds as a prelude to human skin restoration

The anticipated rise in chronic diseases is set to be a driving factor in the prospective growth of the 3D bioprinting market. Chronic diseases, persisting over extended periods-typically three months or more, and often for a person's lifetime-have increasingly utilized 3D bioprinting for creating tissue models, aiding in chronic disease research and potential organ replacement therapies. For example, as per the World Health Organization's September 2022 report, approximately 41 million deaths globally annually, representing 74% of fatalities, are attributed to non-communicable diseases (NCDs) or chronic diseases. This alarming figure includes 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Consequently, the upsurge in chronic diseases is a significant driver behind the growth of the 3D bioprinting market.

Leading companies in the 3D bioprinting market are focusing on developing next-generation bioprinters for use in tissue engineering and regenerative medicine. A bio 3D printer is a specialized device that constructs biological structures, such as tissues and organs, using bioinks made from living cells or biocompatible materials. For example, in November 2022, Avay Biosciences, an India-based healthcare company, launched the Mito Plus. This printer facilitates the creation of complex human tissues, addressing critical challenges like organ shortages and improving drug testing methodologies. Key features include precise temperature control (ranging from 4°C to 80°C), a dual-extruder system for multiple biomaterials, inbuilt UV curing to enhance tissue quality, and HEPA filters to maintain a sterile printing environment

Major companies in the 3D bioprinting market are focusing on developing innovative technological solutions, such as 3D bioprinters, to improve precision and efficiency in tissue engineering and regenerative medicine. 3D bioprinters are devices that utilize bioinks containing living cells to produce three-dimensional tissue and organ structures for medical research and regenerative medicine applications. For example, in June 2024, Tethon 3D, a US-based developer of ceramic powder and metal-polymer products, introduced the Bison Bio DLP 3D bioprinter, marking its entry into the bioprinting market. Developed in collaboration with Carima, this advanced printer offers adjustable build sizes (30 X 20 mm, 57 X 32 mm, and 96 X 54 mm) and is compatible with Tethon's proprietary LAP photoinitiator and GelMA hydrogel bioink, crucial for bioprinting living tissues. Measuring 24 X 24 X 24 inches and weighing 75 lbs, the Bison Bio is priced at $19,950 and aims to drive advancements in healthcare by enabling the creation of complex tissues and organs for biomedical research, supporting personalized medicine and regenerative therapies

In May 2022, BICO, a biotechnology company from Sweden focused on 3D bioprinting technology, announced the acquisition of Allegro 3D, Inc. for $6 million. This acquisition is intended to support BICO's strategic objectives by incorporating advanced technology and broadening its market reach. Allegro 3D, Inc., located in San Diego, specializes in light-based printing technology, which enhances BICO's current capabilities.

Major companies operating in the 3D bioprinting market include Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, EnvisionTEC GmbH, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd., ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, GE HealthCare Technologies Inc., 3D Biotek LLC, Nuclera Nucleics Ltd., 3D Fortify Inc., Carbon Inc., Divergent Technologies Inc., Markforged Inc., SprintRay Inc., 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., Shining 3D Tech Co. Ltd., 3Dynamic Systems Ltd., Modern Meadow Inc.

North America was the largest region in the 3D bioprinting market in 2024. The Asia-Pacific is expected to be the fastest-growing region in the 3D bioprinting market during the forecast period. The regions covered in the 3D bioprinting market report analysis are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the 3D bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The 3D bioprinting market consists of sales of extrusion-based bioprinting, inkjet-based bioprinting, laser-assisted bioprinting, and stereolithography bioprinting. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

3D Bioprinting Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d bioprinting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3d bioprinting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The 3d bioprinting market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: 3D Bioprinters; Bioinks
• 2) By Material: Living Cells; Hydrogels; Extracellular Matrices; Other Materials
• 3) By Application: Research Applications; Clinical Application; Other Applications
• 4) By End User: Research Organization And Academic Institutes; Biopharmaceuticals Companies; Hospitals; Other End Users
• Subsegments:
• 1) By 3D Bioprinters: Inkjet 3D Bioprinters; Microextrusion 3D Bioprinters; Laser-Assisted 3D Bioprinters; Stereolithography (SLA) Bioprinters
• 2) By Bioinks: Natural Bioinks; Synthetic Bioinks; Hybrid Bioinks; Hydrogels
• Companies Mentioned: Organovo Holdings Inc.; Allevi Inc.; Cellink AB; Aspect Biosystems Ltd.; 3D Systems Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. 3D Bioprinting Market Characteristics

3. 3D Bioprinting Market Trends And Strategies

4. 3D Bioprinting Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global 3D Bioprinting Growth Analysis And Strategic Analysis Framework

• 5.1. Global 3D Bioprinting PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global 3D Bioprinting Market Growth Rate Analysis
• 5.4. Global 3D Bioprinting Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global 3D Bioprinting Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global 3D Bioprinting Total Addressable Market (TAM)

6. 3D Bioprinting Market Segmentation

• 6.1. Global 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 3D Bioprinters
• Bioinks
• 6.2. Global 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Living Cells
• Hydrogels
• Extracellular Matrices
• Other Materials
• 6.3. Global 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Applications
• Clinical Application
• Other Applications
• 6.4. Global 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Organization And Academic Institutes
• Biopharmaceuticals Companies
• Hospitals
• Other End Users
• 6.5. Global 3D Bioprinting Market, Sub-Segmentation Of 3D Bioprinters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inkjet 3D Bioprinters
• Microextrusion 3D Bioprinters
• Laser-Assisted 3D Bioprinters
• Stereolithography (SLA) Bioprinters
• 6.6. Global 3D Bioprinting Market, Sub-Segmentation Of Bioinks, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Bioinks
• Synthetic Bioinks
• Hybrid Bioinks
• Hydrogels

7. 3D Bioprinting Market Regional And Country Analysis

• 7.1. Global 3D Bioprinting Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global 3D Bioprinting Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific 3D Bioprinting Market

• 8.1. Asia-Pacific 3D Bioprinting Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China 3D Bioprinting Market

• 9.1. China 3D Bioprinting Market Overview
• 9.2. China 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India 3D Bioprinting Market

• 10.1. India 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan 3D Bioprinting Market

• 11.1. Japan 3D Bioprinting Market Overview
• 11.2. Japan 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia 3D Bioprinting Market

• 12.1. Australia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia 3D Bioprinting Market

• 13.1. Indonesia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea 3D Bioprinting Market

• 14.1. South Korea 3D Bioprinting Market Overview
• 14.2. South Korea 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe 3D Bioprinting Market

• 15.1. Western Europe 3D Bioprinting Market Overview
• 15.2. Western Europe 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK 3D Bioprinting Market

• 16.1. UK 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany 3D Bioprinting Market

• 17.1. Germany 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France 3D Bioprinting Market

• 18.1. France 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy 3D Bioprinting Market

• 19.1. Italy 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain 3D Bioprinting Market

• 20.1. Spain 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe 3D Bioprinting Market

• 21.1. Eastern Europe 3D Bioprinting Market Overview
• 21.2. Eastern Europe 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia 3D Bioprinting Market

• 22.1. Russia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America 3D Bioprinting Market

• 23.1. North America 3D Bioprinting Market Overview
• 23.2. North America 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA 3D Bioprinting Market

• 24.1. USA 3D Bioprinting Market Overview
• 24.2. USA 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada 3D Bioprinting Market

• 25.1. Canada 3D Bioprinting Market Overview
• 25.2. Canada 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America 3D Bioprinting Market

• 26.1. South America 3D Bioprinting Market Overview
• 26.2. South America 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil 3D Bioprinting Market

• 27.1. Brazil 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East 3D Bioprinting Market

• 28.1. Middle East 3D Bioprinting Market Overview
• 28.2. Middle East 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa 3D Bioprinting Market

• 29.1. Africa 3D Bioprinting Market Overview
• 29.2. Africa 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. 3D Bioprinting Market Competitive Landscape And Company Profiles

• 30.1. 3D Bioprinting Market Competitive Landscape
• 30.2. 3D Bioprinting Market Company Profiles
  • 30.2.1. Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Allevi Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Cellink AB Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Aspect Biosystems Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. 3D Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

31. 3D Bioprinting Market Other Major And Innovative Companies

• 31.1. Cyfuse Biomedical KK
• 31.2. EnvisionTEC GmbH
• 31.3. Poietis SA
• 31.4. TeVido BioDevices
• 31.5. Nano3D Biosciences Inc.
• 31.6. Digilab Inc.
• 31.7. RegenHU Ltd.
• 31.8. GeSiM mbH
• 31.9. Advanced Solutions Life Sciences LLC
• 31.10. Regenovo Biotechnology Co. Ltd.
• 31.11. Regemat 3D S.L.
• 31.12. Bio3D Technologies
• 31.13. Stratasys Ltd.
• 31.14. ROKIT Healthcare Co. Ltd.
• 31.15. Inventia Life Science Pvt. Ltd.

32. Global 3D Bioprinting Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 3D Bioprinting Market

34. Recent Developments In The 3D Bioprinting Market

35. 3D Bioprinting Market High Potential Countries, Segments and Strategies

• 35.1 3D Bioprinting Market In 2029 - Countries Offering Most New Opportunities
• 35.2 3D Bioprinting Market In 2029 - Segments Offering Most New Opportunities
• 35.3 3D Bioprinting Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer